Table of Contents

1. Methodology and Scope

1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Mode of purchase
1.1.5. Distribution channel
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. RO japan internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights

3. U.S. Wound Care Market Variables, Trends & Scope

3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing Adoption of Bioactive Therapies for Late-Stage Wounds Pushes the Growth of the Market
3.2.2. Market restraint analysis
3.2.2.1. High Costs Associated with Advanced Wound Care Products May Impede the Growth of the Market
3.2.3. Market opportunity analysis
3.2.3.1. Launch of Technologically Advanced Wound Treatment Products to Augment Market Growth
3.3. U.S. Wound Care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape

4. U.S. Wound Care Market: Product Estimates & Trend Analysis

4.1. Definitions and Scope
4.1.1. Advanced wound dressing
4.1.2. Surgical wound care
4.1.3. Traditional wound care
4.1.4. Wound therapy devices
4.2. Product Market Share, 2024 & 2033
4.3. Segment Dashboard
4.4. U.S. Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
4.5.1. Advanced wound dressing
4.5.1.1. Advanced wound dressing market estimates and forecast 2025 to 2033 (USD Million)
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2025 to 2033 (USD Million)
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2025 to 2033 (USD Million)
4.5.1.4. Film dressings
4.5.1.4.1. Film dressings market estimates and forecast 2025 to 2033 (USD Million)
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2025 to 2033 (USD Million)
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel dressings market estimates and forecast 2025 to 2033 (USD Million)
4.5.1.7. Collagen dressings
4.5.1.7.1. Collagen dressings market estimates and forecast 2025 to 2033 (USD Million)
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2025 to 2033 (USD Million)
4.5.2. Surgical wound care
4.5.2.1. Surgical wound care market estimates and forecast 2025 to 2033 (USD Million)
4.5.2.2. Sutures & staples
4.5.2.2.1. Sutures & staples market estimates and forecast 2025 to 2033 (USD Million)
4.5.2.3. Tissue adhesives & sealants
4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2025 to 2033 (USD Million)
4.5.2.4. Anti-infective dressing
4.5.2.4.1. Anti-infective dressing market estimates and forecast 2025 to 2033 (USD Million)
4.5.3. Traditional wound care
4.5.3.1. Traditional wound care market estimates and forecast 2025 to 2033 (USD Million)
4.5.3.2. Medical tapes
4.5.3.2.1. Medical tapes market estimates and forecast 2025 to 2033 (USD Million)
4.5.3.3. Cotton
4.5.3.3.1. Cotton market estimates and forecast 2025 to 2033 (USD Million)
4.5.3.4. Bandages
4.5.3.4.1. Bandages market estimates and forecast 2025 to 2033 (USD Million)
4.5.3.5. Gauzes
4.5.3.5.1. Gauzes market estimates and forecast 2025 to 2033 (USD Million)
4.5.3.6. Sponges
4.5.3.6.1. Sponges market estimates and forecast 2025 to 2033 (USD Million)
4.5.3.7. Cleansing agents
4.5.3.7.1. Cleansing agents market estimates and forecast 2025 to 2033 (USD Million)
4.5.4. Wound therapy devices
4.5.4.1. Wound therapy devices market estimates and forecast 2018 to 2030s, (USD Million)
4.5.4.2. Negative pressure wound therapy
4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2025 to 2033 (USD Million)
4.5.4.3. Oxygen and hyperbaric oxygen equipment
4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2025 to 2033 (USD Million)
4.5.4.4. Electric stimulation devices
4.5.4.4.1. Electric stimulation devices market estimates and forecast 2025 to 2033 (USD Million)
4.5.4.5. Pressure relief devices
4.5.4.5.1. Pressure relief devices market estimates and forecast 2025 to 2033 (USD Million)
4.5.4.6. Others
4.5.4.6.1. Others market estimates and forecast 2025 to 2033 (USD Million)

5. U.S. Wound Care Market: Application Estimates & Trend Analysis

5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2024 & 2033
5.3. Segment Dashboard
5.4. U.S. Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2025 to 2033 for the following
5.5.1. Acute Wounds
5.5.1.1. Acute wounds market estimates and forecast 2025 to 2033 (USD Million)
5.5.1.2. Surgical & traumatic wounds
5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2025 to 2033 (USD Million)
5.5.1.3. Burns
5.5.1.3.1. Burns market estimates and forecast 2025 to 2033 (USD Million)
5.5.2. Chronic Wounds
5.5.2.1. Chronic wounds market estimates and forecast 2025 to 2033 (USD Million)
5.5.2.2. Diabetic foot ulcers
5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2025 to 2033 (USD Million)
5.5.2.3. Pressure ulcers
5.5.2.3.1. Pressure ulcers market estimates and forecast 2025 to 2033 (USD Million)
5.5.2.4. Venous leg ulcers
5.5.2.4.1. Venous leg ulcers market estimates and forecast 2025 to 2033 (USD Million)
5.5.2.5. Others chronic wounds
5.5.2.5.1. Others chronic wounds market estimates and forecast 2025 to 2033 (USD Million)

6. U.S. Wound Care Devices: End-Use Estimates & Trend Analysis

6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Outpatient facilities
6.1.3. Home care
6.1.4. Research & manufacturing
6.2. End Use Market Share, 2024 & 2033
6.3. Segment Dashboard
6.4. U.S. Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2025 to 2033 (USD Million)
6.5.2. Outpatient facilities
6.5.2.1. Outpatient facilities centers market estimates and forecast 2025 to 2033 (USD Million)
6.5.3. Home care
6.5.3.1. Home care market estimates and forecast 2025 to 2033 (USD Million)
6.5.4. Research & manufacturing
6.5.4.1. Research & manufacturing market estimates and forecast 2025 to 2033 (USD Million)

7. U.S. Wound Care Devices: Mode of Purchase Estimates & Trend Analysis

7.1. Definitions and Scope
7.1.1. Prescribed
7.1.2. Non-prescribed (OTC)
7.2. Mode of Purchase Market Share, 2024 & 2033
7.3. Segment Dashboard
7.4. U.S. Wound Care Market by Mode of Purchase Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Prescribed
7.5.1.1. Prescribed market estimates and forecast 2025 to 2033 (USD Million)
7.5.2. Non-prescribed (OTC)
7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2025 to 2033 (USD Million)

8. U.S. Wound Care Devices: Distribution Channel Estimates & Trend Analysis

8.1. Definitions and Scope
8.1.1. Institutional sales
8.1.2. Retail sales
8.2. Distribution Channel Market Share, 2024 & 2033
8.3. Segment Dashboard
8.4. U.S. Wound Care Market by Distribution Channel Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Institutional sales
8.5.1.1. Institutional sales market estimates and forecast 2025 to 2033 (USD Million)
8.5.2. Retail sales
8.5.2.1. Retail sales market estimates and forecast 2025 to 2033 (USD Million)

9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Smith & Nephew PLC
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Mölnlycke Health Care AB
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. ConvaTec Group PLC
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Baxter International
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. URGO Medical
9.3.8.1. Financial performance
9.3.8.2. Product benchmarking
9.3.8.3. Strategic initiatives
9.3.9. Coloplast Corp.
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Medtronic
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. 3M
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Derma Sciences (Integra LifeSciences)
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Medline Industries, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
9.3.14. 3M
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Product benchmarking
9.3.14.4. Strategic initiatives
9.3.15. Ethicon (Johnson & Johnson)
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Product benchmarking
9.3.15.4. Strategic initiatives
9.3.16. B. Braun SE
9.3.16.1. Company overview
9.3.16.2. Financial performance
9.3.16.3. Product benchmarking
9.3.16.4. Strategic initiatives
9.3.17. Cardinal Health, Inc.
9.3.17.1. Company overview
9.3.17.2. Financial performance
9.3.17.3. Product benchmarking
9.3.17.4. Strategic initiatives
9.3.18. Organogenesis Inc
9.3.18.1. Company overview
9.3.18.2. Financial performance
9.3.18.3. Product benchmarking
9.3.18.4. Strategic initiatives
9.3.19. MIMEDX Group, Inc.
9.3.19.1. Company overview
9.3.19.2. Financial performance
9.3.19.3. Product benchmarking
9.3.19.4. Strategic initiatives